Hampstead Health offers treatment for adults living with treatment-resistant depression. Spravato® (intranasal esketamine) is a TGA-approved therapy that works differently from traditional antidepressants, providing rapid relief for some individuals where other treatments have not been effective. Administered under clinical supervision in a safe, supportive environment, Spravato® may offer hope to those struggling with persistent depressive symptoms. 

Referral from a psychiatrist is required.